Clinical Trial Update: SV2A Density Cannabis Use Disorder [EARLY_Phase 1]

View source ↗

Summary

An EARLY_PHASE1 Yale-sponsored clinical trial is evaluating SV2A density in Cannabis Use Disorder and healthy individuals; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• SV2A Density PET Imaging Agent (SV2A PET tracer)

Snippet

Sponsor: Yale University | Conditions: Cannabis Use Disorder, Healthy | EARLY_Phase 1 | Status: RECRUITING